Premium
A randomised, controlled, double‐blind trial of ultrasound‐guided phrenic nerve block to prevent shoulder pain after thoracic surgery
Author(s) -
BlichfeldtEckhardt M. R.,
Laursen C. B.,
Berg H.,
Holm J. H.,
Hansen L. N.,
Ørding H.,
Andersen C.,
Licht P. B.,
Toft P.
Publication year - 2016
Publication title -
anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.839
H-Index - 117
eISSN - 1365-2044
pISSN - 0003-2409
DOI - 10.1111/anae.13621
Subject(s) - medicine , ropivacaine , anesthesia , surgery , placebo , phrenic nerve , nerve block , shoulder surgery , respiratory system , alternative medicine , pathology
Summary Moderate to severe ipsilateral shoulder pain is a common complaint following thoracic surgery. In this prospective, parallel‐group study at Odense University Hospital, 76 patients (aged > 18 years) scheduled for lobectomy or pneumonectomy were randomised 1:1 using a computer‐generated list to receive an ultrasound‐guided supraclavicular phrenic nerve block with 10 ml ropivacaine or 10 ml saline (placebo) immediately following surgery. A nerve catheter was subsequently inserted and treatment continued for 3 days. The study drug was pharmaceutically pre‐packed in sequentially numbered identical vials assuring that all participants, healthcare providers and data collectors were blinded. The primary outcome was the incidence of unilateral shoulder pain within the first 6 h after surgery. Pain was evaluated using a numeric rating scale. Nine of 38 patients in the ropivacaine group and 26 of 38 patients in the placebo group experienced shoulder pain during the first 6 h after surgery (absolute risk reduction 44% (95% CI 22–67%), relative risk reduction 65% (95% CI 41–80%); p = 0.00009). No major complications, including respiratory compromise or nerve injury, were observed. We conclude that ultrasound‐guided supraclavicular phrenic nerve block is an effective technique for reducing the incidence of ipsilateral shoulder pain after thoracic surgery.